Page last updated: 2024-12-05
2-methyl-1,2-epoxypropane
Description
2-Methyl-1,2-epoxypropane, also known as propylene oxide, is a colorless liquid with a sweet odor. It is an important industrial chemical, used in the production of polymers, polyols, and other chemicals. Propylene oxide is synthesized by the oxidation of propylene with air or oxygen in the presence of a silver catalyst. It is also a versatile reagent used in organic synthesis, and is an intermediate in the production of several other compounds. Propylene oxide is classified as a flammable liquid and a respiratory irritant. It is also known to be mutagenic and potentially carcinogenic. Research into propylene oxide focuses on its safety, environmental impact, and potential applications in various fields. It's toxicological properties, particularly its ability to act as a mutagen, have led to concerns about its safety, prompting further research and development of safer alternatives. Understanding the chemical properties and potential hazards of propylene oxide is crucial for its safe handling, storage, and use. Studies continue to examine its potential environmental impact, including its degradation and persistence in the environment. '
2-methyl-1,2-epoxypropane: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 11208 |
CHEBI ID | 193943 |
MeSH ID | M0194201 |
Synonyms (56)
Synonym |
uj14mj1wg0 , |
5-17-01-00058 (beilstein handbook reference) |
unii-uj14mj1wg0 |
ec 209-193-8 |
oxirane, 2,2-dimethyl- |
nsc24249 |
2,2-dimethyloxirane |
isobutylene oxide |
propane,2-epoxy-2-methyl- |
2-methyl-1,2-epoxypropane |
2-methyl-1-propene oxide |
1,1-dimethylethylene oxide |
oxirane,2-dimethyl- |
nsc-24249 |
1,2-epoxy-2-methylpropane |
558-30-5 |
isobutene oxide |
isobutylene epoxide |
1,2-isobutylene oxide |
einecs 209-193-8 |
1,2-epoxyisobutane |
nsc 24249 |
ccris 4380 |
propane, 1,2-epoxy-2-methyl- |
brn 0102408 |
isobutyleneoxide |
1,2-epoxy-2-methylpropane, 97% |
gelkghvafrcjna-uhfffaoysa- |
inchi=1/c4h8o/c1-4(2)3-5-4/h3h2,1-2h3 |
2-methylpropylene oxide |
I0323 |
CHEBI:193943 |
AKOS009157227 |
1,2-epoxy-isobutane |
1,1-dimethyloxirane |
A830830 |
FT-0606466 |
isobutylenoxide |
2,2-dimethyloxiran |
2,2-dimethyl oxirane |
2,2-dimethyl-oxirane |
1,2-epoxy-2-methyl-propane |
2, 2-dimethyloxirane |
DTXSID7060330 |
W-109563 |
mfcd00066354 |
2-methyl-1, 2-epoxypropane |
1, 1-dimethylethylene oxide |
1, 2-isobutylene oxide |
1,2-epoxy-2-methylpropane, 8ci |
ethylene oxide, .alpha.,.alpha.-dimethyl- |
methyl-1,2-epoxypropane, 2- |
ccris-4380 |
2-methyl-1-propenoxide |
EN300-36458 |
25068-10-4 |
Research Excerpts
Toxicity
Dosage Studied
Drug Classes (1)
Class | Description |
epoxide | Any cyclic ether in which the oxygen atom forms part of a 3-membered ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 21.41 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.42 (4.65) | Search Engine Demand Index | 18.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |